| Role of angiotensin II AT1 receptor activation in cardiovascular diseases S Billet, F Aguilar, C Baudry, E Clauser Kidney international 74 (11), 1379-1384, 2008 | 134 | 2008 |
| Understanding the role of stromal fibroblasts in cancer progression M Tripathi, S Billet, NA Bhowmick Cell adhesion & migration 6 (3), 231-235, 2012 | 119 | 2012 |
| Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE) KE Bernstein, XZ Shen, RA Gonzalez-Villalobos, S Billet, ... Current opinion in pharmacology 11 (2), 105-111, 2011 | 93 | 2011 |
| The carboxypeptidase ACE shapes the MHC class I peptide repertoire XZ Shen, S Billet, C Lin, D Okwan-Duodu, X Chen, AE Lukacher, ... Nature immunology 12 (11), 1078-1085, 2011 | 92 | 2011 |
| Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice S Billet, S Bardin, S Verp, V Baudrie, A Michaud, S Conchon, ... The Journal of clinical investigation 117 (7), 1914-1925, 2007 | 92 | 2007 |
| Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner M Kato, VR Placencio-Hickok, A Madhav, S Haldar, M Tripathi, S Billet, ... Oncogene 38 (5), 716-730, 2019 | 77 | 2019 |
| Angiotensin-converting enzyme is required for normal myelopoiesis C Lin, V Datta, D Okwan-Duodu, X Chen, S Fuchs, R Alsabeh, S Billet, ... The FASEB Journal 25 (4), 1145, 2011 | 74 | 2011 |
| Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells R Cheng, S Billet, C Liu, S Haldar, D Choudhury, M Tripathi, M Hav, ... Oncogene 39 (7), 1543-1556, 2020 | 72 | 2020 |
| Targeted delivery of paclitaxel to EphA2-expressing cancer cells S Wang, R Noberini, JL Stebbins, S Das, Z Zhang, B Wu, S Mitra, S Billet, ... Clinical Cancer Research 19 (1), 128-137, 2013 | 69 | 2013 |
| Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion RA Gonzalez-Villalobos, S Billet, C Kim, R Satou, S Fuchs, KE Bernstein, ... Journal of the American Society of Nephrology 22 (3), 449-459, 2011 | 64 | 2011 |
| NOD‐like receptor C4 inflammasome regulates the growth of colon cancer liver metastasis in NAFLD K Ohashi, Z Wang, YM Yang, S Billet, W Tu, M Pimienta, SL Cassel, ... Hepatology 70 (5), 1582-1599, 2019 | 61 | 2019 |
| Reduction of circulating Cancer cells and metastases in breast-Cancer models by a potent EphA2-agonistic peptide–drug conjugate AF Salem, S Wang, S Billet, JF Chen, P Udompholkul, L Gambini, ... Journal of medicinal chemistry 61 (5), 2052-2061, 2018 | 58 | 2018 |
| Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors XZ Shen, AE Lukacher, S Billet, IR Williams, KE Bernstein Journal of biological chemistry 283 (15), 9957-9965, 2008 | 54 | 2008 |
| Gingival fibroblasts resist apoptosis in response to oxidative stress in a model of periodontal diseases R Cheng, D Choudhury, C Liu, S Billet, T Hu, NA Bhowmick Cell Death Discovery 1 (1), 1-8, 2015 | 46 | 2015 |
| Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance C Liu, S Billet, D Choudhury, R Cheng, S Haldar, A Fernandez, S Biondi, ... Neoplasia 23 (1), 118-128, 2021 | 37 | 2021 |
| New insights into the role of angiotensin-converting enzyme obtained from the analysis of genetically modified mice XZ Shen, HD Xiao, P Li, CX Lin, S Billet, D Okwan-Duodu, JW Adams, ... Journal of Molecular Medicine 86, 679-684, 2008 | 32 | 2008 |
| Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment Z Wang, SY Kim, W Tu, J Kim, A Xu, YM Yang, M Matsuda, L Reolizo, ... Cell Metabolism 35 (7), 1209-1226. e13, 2023 | 27 | 2023 |
| Prostate cancer metastases are strongly inhibited by agonistic Epha2 ligands in an orthotopic mouse model AF Salem, L Gambini, S Billet, Y Sun, H Oshiro, M Zhao, RM Hoffman, ... Cancers 12 (10), 2854, 2020 | 18 | 2020 |
| Modulation of cabozantinib efficacy by the prostate tumor microenvironment M Tripathi, S Nandana, S Billet, KA Cavassani, R Mishra, LWK Chung, ... Oncotarget 8 (50), 87891, 2017 | 16 | 2017 |
| The AT1A receptor “gain-of-function” mutant N111S/Δ329 is both constitutively active and hyperreactive to angiotensin II S Billet, S Bardin, R Tacine, E Clauser, S Conchon American Journal of Physiology-Endocrinology and Metabolism 290 (5), E840-E848, 2006 | 15 | 2006 |
